Who owns LAVA THERAPEUTICS NV?
- Ticker: LVTX
- CUSIP Number: n51517105
Tip: Access positions for across all investors
Analyze quarterly positions in Lava Therapeutics Nv with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lava Therapeutics Nv stock
Who bought or sold LAVA THERAPEUTICS NV this quarter?
There are no current stakeholders of Lava Therapeutics Nv.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Lava Therapeutics Nv?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Shay Capital | Sep 2025 | 2.5M | $4.0M |
| Redmile Group | Sep 2025 | 2.1M | $3.2M |
| BML Capital Management | Sep 2025 | 2.0M | $3.1M |
| Sanofi | Sep 2025 | 1.9M | $3.0M |
| Merck & Co | Sep 2025 | 1.1M | $1.8M |
| Gts Securities | Sep 2025 | 200k | $312k |
| Rangeley Capital | Sep 2025 | 165k | $257k |
| Susquehanna International | Sep 2025 | 154k | $241k |
| Pnc Financial Services | Sep 2025 | 65k | $101k |
| Citadel Advisors | Sep 2025 | 53k | $83k |